Nurse Practitioner, Family · Lubbock, TX
NPI
1912475344
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4407 6th St
Lubbock, TX, 79416
Phone (806) 771-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,822
122 services
Medicare patients, 2024
18
Average age 67
Drug cost, 2024
$57K
230 prescriptions
Company payments, 2024
$47.96
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara V Tello was code 99407 (behavioral health services), 53 times for 15 patients. In total Sara V Tello billed 122 services in 10 codes, and Medicare paid $6,822.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99407 Behavioral Health Services | Office | 53 | 15 | $23.78 | $1,260 |
| 99214 Office E&M - Established | Office | 28 | 12 | $83.96 | $2,351 |
By year: 2022 $9,119 for 99 services; 2023 $7,512 for 110 services; 2024 $6,822 for 122 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara V Tello prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 107 prescriptions and refills. In total Sara V Tello wrote 230 Medicare prescriptions that cost $57K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bupropion Xl Bupropion Hcl | 107 | 123 | 26 | $1,128 |
| Varenicline Tartrate Generic | 96 | 165 | 46 | $35K |
| Nicotrol Ns Nicotine | 27 | 37 | 27 | $21K |
Brand drugs: 27 claims; generic drugs: 203 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sara V Tello $47.96 ($47.96 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $25.77.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.